1. Home
  2. TPST vs VRAR Comparison

TPST vs VRAR Comparison

Compare TPST & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • VRAR
  • Stock Information
  • Founded
  • TPST 2011
  • VRAR 2016
  • Country
  • TPST United States
  • VRAR United States
  • Employees
  • TPST N/A
  • VRAR N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • VRAR Retail: Computer Software & Peripheral Equipment
  • Sector
  • TPST Health Care
  • VRAR Technology
  • Exchange
  • TPST Nasdaq
  • VRAR Nasdaq
  • Market Cap
  • TPST 40.4M
  • VRAR 42.4M
  • IPO Year
  • TPST N/A
  • VRAR 2021
  • Fundamental
  • Price
  • TPST $0.86
  • VRAR $1.55
  • Analyst Decision
  • TPST Strong Buy
  • VRAR Strong Buy
  • Analyst Count
  • TPST 3
  • VRAR 1
  • Target Price
  • TPST $21.67
  • VRAR $4.67
  • AVG Volume (30 Days)
  • TPST 877.6K
  • VRAR 316.7K
  • Earning Date
  • TPST 03-18-2025
  • VRAR 02-13-2025
  • Dividend Yield
  • TPST N/A
  • VRAR N/A
  • EPS Growth
  • TPST N/A
  • VRAR N/A
  • EPS
  • TPST N/A
  • VRAR N/A
  • Revenue
  • TPST N/A
  • VRAR $9,230,197.00
  • Revenue This Year
  • TPST N/A
  • VRAR $39.02
  • Revenue Next Year
  • TPST N/A
  • VRAR N/A
  • P/E Ratio
  • TPST N/A
  • VRAR N/A
  • Revenue Growth
  • TPST N/A
  • VRAR N/A
  • 52 Week Low
  • TPST $0.70
  • VRAR $0.50
  • 52 Week High
  • TPST $6.00
  • VRAR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • TPST 40.89
  • VRAR 39.84
  • Support Level
  • TPST $0.85
  • VRAR $1.55
  • Resistance Level
  • TPST $0.95
  • VRAR $1.73
  • Average True Range (ATR)
  • TPST 0.05
  • VRAR 0.18
  • MACD
  • TPST -0.00
  • VRAR -0.01
  • Stochastic Oscillator
  • TPST 9.45
  • VRAR 10.58

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

Share on Social Networks: